The UCL Great Ormond Street Institute of Child Health is an academic department of the Faculty of Population Health Sciences of University College London and is located in London, United Kingdom.

During the past decade, UCL Institute of Child Health conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCL Institute of Child Health" #1 sponsor was "Institute of Child Health" with 11 trials, followed by "Genethon" with 3 trials sponsored, "PTC Therapeutics" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCL Institute of Child Health" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Great Ormond Street Hospital for Children NHS Foundation Trust" with 2 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Cooperative International Neuromuscular Research Group" with 1 trials as a collaborator and "Institute of Myology" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "UCL Institute of Child Health" are "Duchenne Muscular Dystrophy" (8 trials), "Muscular Dystrophy, Duchenne" (3 trials), "Genetic Diseases, Inborn" (2 trials), "Genetic Diseases, X-Linked" (2 trials) and "Muscular Diseases" (2 trials). Many other conditions were trialed in "UCL Institute of Child Health" in a lesser frequency.

Most popular intervention types in "UCL Institute of Child Health" are "Drug" (16 trials), "Biological" (5 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ataluren" (2 trials), "Bosentan" (2 trials), "Antibiotic impregnated polyurethane CVC (minocycline and rifampicin)" (1 trials) and "Autologous CD34+ cells transduced with WASP lentiviral vector" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCL Institute of Child Health" are 25 trials for "All" genders, 13 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UCL Institute of Child Health". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in UCL Institute of Child Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCL Institute of Child Health, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".